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The potency of the fs260 connexin43 mutant to impair keratinocyte
differentiation is distinct from other disease-linked connexin43 mutants
Jared M. CHURKO, Stephanie LANGLOIS, Xinyue PAN, Qing SHAO and Dale W. LAIRD1
Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, Canada N6A 5C1
Although there are currently 62 mutants of Cx43 (connexin43)
that can cause ODDD (oculodentodigital dysplasia), only two
mutants have also been reported to cause palmar plantar
hyperkeratosis.TodeterminehowmutantsofCx43canleadtothis
skindisease,REKs(ratepidermalkeratinocytes)wereengineered
to express an ODDD-associated Cx43 mutant always linked to
skin disease (fs260), an ODDD-linked Cx43 mutant which has
been reported to sometimes cause skin disease (fs230), Cx43 mu-
tants which cause ODDD only (G21R, G138R), a mouse Cx43
mutant linked to ODDD (G60S), a non-disease-linked truncated
Cx43mutantthatistrappedintheendoplasmicreticulum( 244*)
or full-length Cx43. When grown in organotypic cultures, of
all the mutants investigated, only the fs260-expressing REKs
consistently developed a thinner stratum corneum and expressed
lower levels of Cx43, Cx26 and loricrin in comparison with
REKs overexpressing wild-type Cx43. REKs expressing the
fs260 mutant also developed a larger organotypic vital layer
after acetone-induced injury and exhibited characteristics of
parakeratosis. Collectively, our results suggest that the increased
skin disease burden exhibited in ODDD patients harbouring the
fs260 mutant is probably due to multiple additive effects cause by
the mutant during epidermal differentiation.
Key words: connexin43, gap junction, keratinocyte, organotypic
epidermis, palmar plantar hyperkeratosis.
INTRODUCTION
Direct cell-to-cell communication relies heavily on the passage
of small molecules through gap junctions [1]. Structurally, gap
junctions are composed of connexin proteins which oligomerize
in the Golgi apparatus to form connexons [2]. Connexons
are transported to the cell surface and dock with connexons
from an adjacent cell to form functional channels [3]. Given
that connexins and gap junctions have a half-life of only
1–5 h both in vitro and in vivo, constant regulatory control
of connexin translation, oligomerization, delivery to the cell
surface and assembly are all critical for the proper regulation
of GJIC (gap junctional intercellular communication). When
regulatory processes involved in the life cycle of connexins
become disrupted, GJIC is compromised and disease may result.
For example, disease-linked mutations in the gene encoding
Cx43 (connexin43) have been shown to sequester endogenous
and mutant Cx43 in intracellular compartments [4], and inhibit
the passage of small molecules through gap junction channels
and hemichannels [5,6]. Clinically, germ line mutations in nine
connexin gene family members lead to human diseases that
include skin diseases (e.g. Cx26, Cx43) [7], cataracts (e.g. Cx45,
Cx50)[8],deafness(e.g.Cx26)[9],arrhythmias(e.g.Cx40,Cx43)
[10], Charcot–Marie–Tooth disease (e.g. Cx32) [11] and ODDD
(oculodentodigital dysplasia) (e.g. Cx43) [12].
ODDD was ﬁrst described as a disease displaying craniofacial
abnormalities (microphthalmia, dental anomalies, small nose and
hypotrichosis), type III syndactyly and missing toe phalanges
[13].Sinceitsinitialcharacterization,spasticparaparesis,cerebral
white matter abnormalities [14] and ectodermal abnormalities
[12,15,16]havealsobeenassociatedwithODDD.ODDDisarare
condition as less than 1000 cases having been fully documented,
although now that the genetic link to the disease is known, the
number of reported cases is likely to grow substantially [12]. To
date, ODDD is associated with 62 familial or sporadic mutations
in the gene encoding Cx43 with the majority (∼85%)b e i n g
dominant missense mutations [12]. Functional assays employing
some of these mutations have found that the mutants encoded are
dominant-negative and result in a drastic reduction in normal
Cx43 function [4,6]. These mutations are associated with a
wide array of phenotypic outcomes and, generally, domain-
speciﬁc mutations were not found to correlate with a speciﬁc
ODDD symptom. For example, ODDD has been diagnosed in
patients having mutations in the N-terminal end (e.g. Y17S and
G21R), ﬁrst extracellular loop (e.g. A40V, G60S and P59S),
cytoplasmic loop (e.g. V96M and G138R), second extracellular
loop (e.g. H194P) and C-terminal tail (e.g. fs230 and fs260) [12].
Although most of these mutations often result in syndactyly and
cranial facial abnormalities, two ODDD mutants that truncate
the C-terminal tail (fs230 and fs260) have been reported to
additionally cause the skin disease palmar plantar hyperkeratosis
[17,18]. Although both of these mutants have been reported to
cause palmar plantar hyperkeratosis, a newly identiﬁed patient
expressing the fs230 mutant did not exhibit this skin disease
phenotype [19]. Importantly, the fs260 mutant has a polypeptide
extension of 46 non-connexin-related amino acids before a stop
codon is encountered, whereas the fs230 mutant only has a
six-amino-acid extension prior to reaching a stop codon [17].
Thus, although these two mutants both lack the C-terminal tail,
theydifferextensivelyinnon-connexinpolypeptidesequencethat
may contribute to the disease phenotype in the skin.
Palmar plantar hyperkeratosis has been linked to a wide array
of abnormal processes. Palmar plantar hyperkeratosis involves a
thickening of the epidermis in the friction and weight-bearing
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surfaces of the palms and the plantar region of the feet.
Congenitally, palmar plantar hyperkeratosis can also be caused
by mutations in the genes which code for epidermal proteins.
Mutant keratin 1, keratin 10 [20], Cx26 (Vohwinkel’s syndrome)
[21] and desmosomal proteins [22] have all been reported to
be genetically linked to palmar plantar hyperkeratosis. In the
case of Cx43 mutations, it is currently not known whether
the mechanism by which Cx43 mutants cause palmar plantar
hyperkeratosis is somehow associated to these other skin disease-
linked proteins. However, it has previously been shown that a
mutant Cx26 which causes palmar plantar hyperkeratosis can
have transdominant effects on Cx43 [23]. Thus it may also be
possible that mutant Cx43 causes palmar plantar hyperkeratosis
through transdominant effects on Cx26. It is also reasonable to
assumethat,sincekeratins,desmosomesandtightjunctionsareall
responsible for maintaining the integrity of the epidermal barrier,
Cx43 mutants that disrupt any one of these components may
lead to disruptions in the membrane barrier and contribute to
palmar plantar hyperkeratosis. In the present study we examined
the mechanism by which mutations in the gene encoding Cx43
canaffectskindifferentiationandhowsomemutationsassociated
with ODDD, but not others, can lead to skin disease.
MATERIALS AND METHODS
Cell lines
REKs (rat epidermal keratinocytes) were originally characterized
by Baden and Kubilus [24] and were grown in REK
growth medium composed of DMEM (Dulbecco’s modiﬁed
Eagle’s medium) supplemented with 2 mM L-glutamine, 10%
fetal bovine serum, 100 μg/ml streptomycin and 100 units/ml
penicillin.
Transfection and infection
Transfection of packaging 293 GPG cells was carried out using
the previously reported and characterized AP2 vector encoding
full-length Cx43 tagged with GFP (green ﬂuorescent protein)
(Cx43–GFP) or the Cx43 mutants G21R, G60S, G138R,  244
with mutations G58R and S158A ( 244*) [25] and fs260. In
addition, a fs230 mutation was also created using the Qiagen
QuikChange site-directed mutagenesis kit with the primers 5
 -
ATCATTGAACTCTTCTGTTTTCTTCAAGGGCGTTAAGGA-
TCGGG(forward)and5
 -CCCGATCCTTAACGCCCTTGAAG-
AAAACAGAAGAGTTCAATGAT (reverse) for human Cx43
pcDNA3.1. Untagged fs230 pcDNA3.1 was used to rule out
effects caused by the GFP tag. The mutant fs230 sequence was
then fused in frame into a EGFP (enhanced GFP)-N1 (Clontech)
vector and further incorporated into a AP2 vector using the
primers 5
 -ATCTCGACATGGGTGACTGGAGCGC (forward)
and 5
 - GGTGGATCCGGACGCCCTTGAAGAA (reverse). The
fs230–GFP mutant construct encodes the ﬁrst 229 amino acids of
Cx43, six amino acids resulting from the frame shift (CFLEGR),
seven amino acid linkers (PDPPLAT) and the EGFP protein
sequence.
Toperformtransfectionsofpackaging293cells,2.5 mlofOpti-
MEM was placed into two separate 5 ml tubes. The AP2 vector
(10 μg) was placed into one tube while 15 μl of Lipofectamine
TM
2000 was added to the second tube. Within 5 min, both tubes
were combined and were incubated for 20 min. Packaging cells
in a 100-mm-diameter culture dish were then washed twice
in Opti-MEM medium and the combined Lipofectamine
TM/AP2
vector solution was administered on to the growing packaging
293 cells. After 6 h, the Lipofectamine
TM solution was aspirated
and the packaging cells were grown overnight in low-glucose
DMEM supplemented with 10% fetal bovine serum, 10 mg/ml
tetracyclineand20 mg/mlG418.Thenextday,5 mloffreshREK
growth medium was placed on to the transfected packaging cells
andviralcollectionsweremadeeverydayforfourdays.Collected
viral medium was concentrated by centrifugation in sealed 5.1 ml
tubes for 90 min in a Beckman TL100 ultracentrifuge at 4◦Ca t
25000 rev./min (Beckman Instruments). After centrifugation, the
viral pellet was resuspended in 0.5 ml of REK growth medium
a n ds t o r e da t−80◦C.
REKsweregrownto20%conﬂuenceandtheviron-containing
supernatant was exposed to the cells overnight and 5 μg/ml
polybrene was also added to the medium. The next day, fresh
medium was placed on to each REK-infected cell line and these
cell lines were passed ﬁve times before being visualized under
a confocal microscope. Each REK cell line was successfully
transduced, with 95–100% of all cells expressing the Cx43
mutants.
Antibodies and imaging
Immunoﬂuorescence was performed by incubating the cells
overnightwithananti-C-terminalCx43antibody(P4G9;fromthe
FredHutchinsonCancerResearchCenterAntibodyDevelopment
Group, Seattle, WA, U.S.A.) at a dilution of 1:200; an anti-
gp130antibody(todenotetheGolgiapparatus)(gp130,Stressgen,
Ann Arbor, MI, U.S.A.) at a dilution of 1:250; an anti-PDI
(proteindisulﬁdeisomerase) antibody(to denotetheendoplasmic
reticulum) (Stressgen) at a dilution of 1:500; and an anti-
E-cadherin [Zymed (Invitrogen), Carlsbad, CA, U.S.A.; 18-
0223,], anti-claudin-1 [Zymed (Invitrogen); 71-7800] and anti-
occludin [Zymed (Invitrogen); 71-1500] antibodies to view
proteins involved in tight junction and cadherin-based adhesion
at a dilution of 1:250. For secondary antibody labelling, anti-
mouse Alexa Fluor® 555 (Invitrogen; A21425, 1:500) or anti-
rabbit Alexa Fluor® 555 (Invitrogen; A21429, 1:500) antibodies
were used. DAPI (4
 ,6-diamidino-2-phenylindole) staining was
also performed to visualize nuclei, and immunolocalization
imaging was performed using a Zeiss 510 META confocal
microscope. Endogenous Cx43 plaques were labelled with the
P4G9anti-Cx43antibodyandimmunoﬂuorescentimagesofequal
cellcultureareawereacquiredfromboththevectorcontrolandthe
fs230-expressing REKs. An experimenter blinded to the identity
of each cell line was asked to count the number of punctate
structures present at sites of cell–cell apposition in each image.
A gap junction plaque was deﬁned as a punctate immunolabelled
structure of a size greater than 0.1 μm. Thetotal number of nuclei
(as revealed by DAPI staining) was also counted and the number
of punctate structures was divided by the total number of nuclei
per image to get the average number of gap junction plaques per
cell.
Primary antibodies for Western blot analysis were used
as follows: C-terminal Cx43 (Sigma; 1:5000), N-terminal
Cx43 (from the Fred Hutchinson Cancer Research Center
Antibody Development Group; 1:500), p368 Cx43 (Cell
Signaling Technologies; 3511, 1:1000), E-cadherin (Zymed; 18-
0223, 1:1000), occludin (Zymed; 71-1500, 1:1000), loricrin
(Covance; PRB13-145P, 1:1000), Cx26 (Zymed; 71-0500,
1:1000), CK14 (Neomarkers MS-115-P, 1:1000), claudin-1
(Zymed; 71-7800, 1:1000) and GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) (Millipore; MAB374, 1:15,000).
Primary antibodies were diluted in 5% Blotto (Santa Cruz) or
3%BSA(forp368Cx43antibody)andnitrocellulosemembranes
were incubated with each antibody overnight. Depending on the
antibody used, primary antibody detection was performed using
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mouse or rabbit IgG IRDye 800 (Rockland Immunochemicals)
andmouseorrabbitIgGAlexaFluor® 680(Invitrogen)secondary
antibodies. Imaging and densitometry were performed using the
Odyssey software packaged with the Odyssey IR imaging system
(Licor) and data values were plotted using GraphPad Prism v4.0.
Microinjection
REKs were grown to a conﬂuent monolayer and single cells
werepressure-microinjectedwith5%LuciferYellow(Molecular
Probes) [26] using an Eppendorf microinjection system coupled
to a Leica inverted epiﬂuorescent microscope. At 1 min after
microinjectionofLuciferYellowdye,theincidenceofdyetransfer
was determined where dye transfer to one or more adjacent cells
was deemed positive dye transfer.
Organotypic culture
Culture inserts with a 3.0 μm pore size (BD Biosciences) were
coated with a collagen I substrate by mixing 4.25 ml of type I
collagen (BD Biosciences) with 0.5 ml of 10× HBSS (Hanks
balanced salt solution) with Phenol Red (Sigma), 50 μlo f1 . 0M
Hepes (Gibco) and 75–100 μl of 1 M NaOH. Collagen was
polymerized by incubation at 37◦C for 2 h. The collagen layer
was then washed with REK growth medium and REKs were
plated at a density of 1.5×10
5 per well in the upper chamber and
2 ml of REK growth medium was placed in the lower chamber.
After three days, medium from the upper chamber was removed
to expose the conﬂuent REKs to air and to induce differentiation.
Cultures were fed daily by replacing the lower chamber medium
with 2 ml of fresh REK growth medium. After 2 weeks under
differentiation conditions, REKs were processed for histological
and Western blot analysis.
Histological analysis
The 2 week organotypic epidermis was ﬁxed with 3.8% formalin
for 5 h. After 5 h, samples were stored at 4◦Ci nP B S .
Tissue processing, embedding, sectioning (5 μm sections) and
haemotoxylin and eosin staining was performed as previously
described [27].
Acetone-induced injury
Acetone-induced injury was performed as previously described
[28]. After 1 week under differentiation conditions, organotypic
epidermal cultures were left untreated or treated with 0.5 ml of
100% acetone for 30 s. Acetone was then washed off and the
cultures were placed back in the incubator. Acetone treatment
was repeated following 3 days of recovery. At 4 days after the
organotypiccultureswereallowedtorespondtotheacetoneinsult,
they were processed for histological analysis.
Scrape-loaded dye-transfer assay
As previously describe in Lai et al. [5], monolayer cultures of
REKswerewashedoncewithHBSSandascrapewasmadedown
the centre of each culture plate using a 1 ml pipette tip. Wells
were washed once with HBSS and 1.5 mg/ml sulforhodamine
B diluted in HBSS was added to the scraped monolayer. After
10 min on ice, cultures were rinsed with PBS and evaluated under
a ﬂuorescence microscope. As a control, 2 mg/ml rhodamine-
dextran, which cannot pass though gap junctions, was used in a
separate set of wells to control for ﬂuorescence uptake due to
cell death. Since the speciﬁc ﬂuorescence generated from GFP-
tagged Cx43 and mutant variants was high, this prevented the
use a dye which ﬂuoresces with the same emission as GFP. The
area of ﬂuorescence in both groups were outlined and calculated
using ImageJ and the area of dye transfer in the rhodamine-
dextran group was subtracted from the area of dye transfer in
the sulforhodamine group and graphed.
Transepithelial resistance
Transepithelial resistance measurements were taken as reported
previously [29]. Brieﬂy, 1.5×10
4 REKs were seeded on to a
3.0-μm pore transwell insert (BD Biosciences). After 24 h,
a Millicel-ERS voltmeter (Millipore) was used to measure
resistanceinohms.Measurementsweretakenforﬁveconsecutive
days and the measurements from days 2 to 4 were averaged and
graphed.
Statistics
All statistical tests were performed and graphed using GraphPad
Prism v4.0 software. Given the multiple variability factors, assay
comparisons between full-length Cx43-expressing REKs and
each individual mutant REK cell line created were performed
using a t test with a statistical cut-off at P<0.05.
RESULTS
Localization and functional characterization of REKs expressing
mutant Cx43
REKs were engineered to express Cx43 or Cx43 mutants
associated with ODDD to determine how only a subset of Cx43
mutants can cause skin disease. Two frameshift mutants that have
been reported to cause ODDD and palmar plantar hyperkeratosis
(fs230 and fs260) [17,18] and one previously characterized Cx43
trafﬁcking mutant [25] were included in the present study. In
addition, a mouse G60S mutant [30] that results in a phenotype
mimickingtheODDDcondition,andfurtherrepresentsamutation
in the ﬁrst extracellular loop region of Cx43, was also included.
The missense human G21R and G138R mutants were selected
since these mutants represent amino acid changes in Cx43
motifs within the N-terminal tail and cytoplasmic loop domain
respectively. Finally, controls included a REK cell line that
expressed the empty viral vector, as well as an REK cell line
that expressed full-length Cx43. To assist in Cx43 localization,
all Cx43 variants were tagged with GFP at the C-terminal which
has been shown to have only minor effects on Cx43 distribution
and function [31].
Localization of the Cx43 variants when expressed in REKs
revealed that almost all cells were in fact expressing the
Cx43 variants (Figure 1). Similar to the full-length Cx43 and
endogenous Cx43, the G21R and G138R mutants exhibited a
cell surface distribution with abundant gap junction plaques. The
G60S mutant, on the other hand, revealed few plaques with the
bulk of the mutant retained within intracellular compartments.
Both the  244* and fs230 mutants exhibited an endoplasmic
reticulum-likephenotypewithlittletonoevidenceofgapjunction
plaques. Finally, the fs260 mutant was predominantly expressed
in the perinuclear region which we have previously shown to
be localized within the endoplasmic reticulum and the Golgi
apparatus [4]. To determine which subcellular organelle retained
the fs230 mutant, fs230-expressing REKs were immunolabelled
for the endoplasmic reticulum resident protein, PDI, and the
resident Golgi protein, gp130 (Figure 2A). Only a small fraction
of the fs230 mutant was localized to the Golgi apparatus,
whereas a large population of the mutant was retained within the
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Figure 1 Cx43 mutants display different localization proﬁles in REKs
REKs were engineered by retroviral infection to stably express GFP-tagged full-length Cx43
(Cx43), two ODDD mutants that cause skin disease (fs230 and fs260), a C-terminal truncation
with two additional mutations ( 244*), as well as three ODDD-linked mutants not associated
with skin disease (G21R, G60S and G138R). Full-length Cx43, as well as the G21R and G138R
mutants, trafﬁc to the plasma membrane and display large gap junctions, whereas G60S,
 244*, fs230 and fs260 mutant expression is largely conﬁned to intracellular compartments.
Endogenous Cx43 was detected by immunolabelling (red) and nuclei were labelled with DAPI
(blue).
endoplasmic reticulum. Since the majority of the ODDD mutants
examined thus far have been found to be dominant-negative to
endogenous Cx43 [6], the frequency of endogenous Cx43 gap
junction plaques were assessed after labelling with an antibody
directed to the C-terminal domain of Cx43 that is lacking in the
fs230 mutant variant. Compared with cells expressing an empty
vector, the number of detectable endogenous Cx43 gap junction
plaques was reduced when the fs230 mutant was expressed
(Figures2Band2C).Todetermineifthefs230-mutant-expressing
REKs could functionally pass Lucifer Yellow dye to their
neighbouring cell, Lucifer Yellow dye was injected into REKs
expressing the empty vector or the fs230 mutant (Figure 2D and
also see Supplementary Figure S1 at http://www.BiochemJ.org/
bj/429/bj4290473add.htm). The incidence of dye transfer
revealedthat33%thefs230-mutant-expressingREKsand100%
of vector control REKs passed dye. This result suggests that the
over-expressed fs230 mutant is also dominant–negative to the
endogenous Cx43 protein.
To further evaluate the gap junction functional status of each
REK cell line created, a dye transfer assay was performed on a
wounded monolayer (Figure 3). Scraped monolayers were either
treated with a small dye (sulforhodamine B) which can pass
throughgapjunctions(Figure3A)or,asanegativecontrol,alarge
dye (rhodamine-dextran) which cannot spread from one cell to
anotherviagapjunctions.IneachODDDmutantCx43-expressing
cell line, with the exception of the  244*-expressing REKs,
there was a signiﬁcant decrease in the area of dye spread when
comparedwithREKsexpressingthefull-lengthCx43(Figure3B).
These results suggest that all mutants (except  244*) have the
capacity to inhibit the function of endogenous Cx43 consistent
with previous reports [6,29,32].
Organotypic epidermal differentiation is affected by REKs
expressing mutant Cx43
Given that the G21R, G60S, G138R, fs230 and fs260 mutants
inhibit overall gap junction coupling in REKs, we sought
to determine if this reduced cell coupling state could affect
epidermal differentiation (Figure 4). Surprisingly, all REK cell
lines possess the ability to differentiate and establish multiple
cellular layers (Figure 4A). A basal layer, stratum spinosum,
stratum granulosum and stratum corneum developed, suggesting
that epidermal formation can proceed with greatly reduced Cx43
gap junction function. Cx43-expressing REKs predominantly
developed a tightly packed stratum corneum, whereas in other
REKcelllines,spaceswereobservedwithinthestratumcorneum.
In addition, nuclei were often observed in the stratum corneum
of fs260-expressing REKs (typically called parakeratosis). The
differentiation state was also analysed by measuring the total
organotypic architecture and stratum corneum layer thicknesses
(correctedforthespacesinthestratumcorneum)(Figure4B).The
stratum corneum thickness compared with the entire construct
thickness was plotted, and revealed that the G21R, G60S, G138R
and fs260 organotypic epidermal cultures all developed a slightly
thinner stratum corneum. This suggests that the expression
of these ODDD-linked mutants in keratinocytes inhibits the
formation of the stratum corneum.
Mutant Cx43 expression reduced the levels of phosphorylated
Cx43, Cx26 and loricrin
Since endogenous Cx43 is co-expressed with the Cx43 variants
during the differentiation process, the endogenous Cx43 content
was examined in organotypic epidermal cultures (Figure 5A).
Western blots of organotypic epidermal cultures were performed
using an antibody directed to the C-terminus of Cx43 which
only detects endogenous Cx43, as well as an antibody directed
to the N-terminus of Cx43 suitable for detecting all of the
GFP-tagged Cx43 variants. As expected, all REK cell lines
expressed the exogenous Cx43 variants to an approximately
similar level as ectopic Cx43 with the exception that the  244*
mutant was under-expressed and the fs230 mutant was over-
expressed compared with the other mutants (Figures 5A and 5B).
It was notable the over-expression of GFP-tagged Cx43 resulted
in an increase in the detectable levels of endogenous Cx43,
suggesting that exogenous Cx43 was serving a role in stabilizing
the endogenous population of Cx43 (Figures 5A and 5B).
Interestingly, the phosphorylated species of endogenous Cx43
(P-Cx43) was reduced (compared with Cx43-over-expressing
cells) when the ODDD-associated Cx43 mutants (G21R, G138R,
fs230andfs260)wereco-expressed(Figure5B).Moreover,when
Cx43 or the  244* mutant was over-expressed, there was an
increase in Cx26 levels, and this increase was not evident when
any other ODDD-linked mutant was over-expressed (Figure 5C).
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Figure 2 The fs230 mutant is predominantly localized within the endoplasmic reticulum and reduces the number of endogenous gap junctions and the extent
of GJIC
(A) fs230-expressing REKs were labelled with antibodies speciﬁc for PDI (endoplasmic reticulum-resident protein) or gp130 (Golgi marker). The bulk of fs230 co-localized primarily with PDI.
Nuclei were stained with DAPI (blue). (B) Both vector control and fs230-expressing REKs were immunolabelled with a C-terminal speciﬁc anti-Cx43 antibody that detected only endogenous Cx43.
Arrows indicate plaque formation. (C) fs230-expressing REKs exhibited a 34% decrease in endogenous Cx43 plaque formation when compared with vector control REKs. (D) Lucifer Yellow dye
was microinjected into both vector control and fs230-expressing REKs. All vector control REKs passed Lucifer Yellow dye, whereas only 33% of fs230-expressing REKs passed dye to neighbouring
cells. *P <0.05.
Of all the mutants tested, only the fs260 mutant reduced the P0
state of endogenous Cx43 when compared with ectopic Cx43,
and this mutant was the only one to signiﬁcantly inhibit the state
of organotypic differentiation as assessed by a reduction in a key
molecular marker of differentiation, loricrin (Figure 5D). Finally,
comparable with the total reduction in endogenous Cx43 levels,
the fs260 mutant was found to reduce the level of the Cx43
species phosphorylated on Ser
368 as detected by an anti-p368
Cx43 phospho-speciﬁc antibody (see Supplementary Figure S2
at http://www.BiochemJ.org/bj/429/bj4290473add.htm).
Reduced barrier function in REKs expressing G60S, G138R and
fs260 Cx43 mutants
Since the epidermal barrier is important for proper epidermal
function, and Cx43 has been found to cross-talk with other
junctional complexes [33,34], we assessed if mutant Cx43-
expressing REKs can disrupt the transepithelial resistance
(Figure6).Collectively,REKswhichexpressedtheG60S,G138R
and fs260 ODDD-linked mutants exhibited lower transepithelial
resistance when compared with ectopic Cx43-expressing REKs
(Figure 6A). However, this reduction in transepithelial resistance
wasnotduetoexpressionlevel(Figures6Cand6D)orsubcellular
localization changes in occludin or claudin-1 or a change in the
celladhesionprotein,E-cadherin(Figure6B).Inaddition,reduced
transepithelialresistancewasnotduetodifferencesincelldeathas
revealed through the use of the MultiTox cell death assay (results
not shown).
Organotypic epidermis expressing fs260 increased the vital layer
thickness after acetone-induced injury
We showed that organotypic cultures expressing the fs260 mutant
developed a thinner stratum corneum thickness and exhibited
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Figure 3 Cx43 mutants reduce dye transfer in REKs
(A) To assess the ability of REKs to transfer dye to neighbouring cells, a scrape assay was
performed using a gap junction permeable dye, sulforhodamine. (B) With the exception of
 244*, there was a signiﬁcant reduction in dye spread in mutant expressing REKs compared
with Cx43-overexpressing REKs. V, empty vector. *P <0.05.
parakeratosis. In addition, REKs expressing the fs260 mutant
lowered the endogenous expression of Cx43, Cx26 and loricrin,
and lowered the transepithelial resistance. Given these changes,
REKs expressing this mutant may develop an aberrant epidermal
barrier. To determine if the expression of mutant Cx43 in
organotypic cultures can affect the response of the epidermal
cultures to injury, an acetone-induced injury and recovery assay
was performed (Figure 7). The stratum corneum in the full-
length Cx43-expressing REKs remained compact after acetone
treatment, whereas nuclei were enriched in the stratum corneum
of fs260-expressing organotypic cultures (Figure 7A). Since
acetone treatment has been shown to induce a proliferative
response[28],vitallayerthicknessmeasurementswerecompared
between untreated and acetone-treated organotypic epidermal
cultures (Figure 7B). Altough no differences were observed
inthevitallayerthicknessinfull-lengthCx43-expressingcultures,
the fs260-expressing cultures formed a signiﬁcantly larger vital
layer thickness after treatment with acetone.
DISCUSSION
Mutations in the gene encoding Cx43 have been conclusively
linked to ODDD. Although there are currently 62 mutations that
have been reported to cause ODDD [12], only the fs230 and
fs260 Cx43 mutants have been reported to result in an additional
skin disease phenotype [17,18]. In the case of the fs230 mutant,
this is not always the case, as a patient recently shown to be
harbouringthismutantexhibitednoevidenceofskindisease[19].
The skin disease associated with these two mutants has been
classiﬁed as palmar planter hyperkeratosis and the molecular
etiology by which Cx43 mutations can cause skin disease
remains unknown. To determine how select mutants can cause
skin disease, various Cx43 constructs were expressed in REKs
and assessed for their cellular localization, functional status,
organotypic differentiation potential, transepithelial resistance,
effect on endogenously expressed connexins and ﬁnally response
tochemicalinjury.Inallassaysperformed,onlythefs260-mutant-
expressing REKs consistently exhibit epidermal defects, and we
propose that the additive effects of these defects ultimately lead
to palmar plantar hyperkeratosis.
Subcellular localization may reﬂect the potency of ODDD mutants
The fs230 and fs260 mutants are similar in that they result in C-
terminal tail truncations but they differ dramatically in the extra
non-connexin amino acid length. The fs230 mutant only has six
extra amino acids [18], whereas the fs260 mutant possesses an
additional 46 amino acids [17]. Although both of these mutants
have been shown to be linked to palmar plantar hyperkeratosis,
the fs230 mutant does not consistently cause this skin disease in
all patients [19], which may be mechanistically linked to their
primary subcellular residence. Immunoﬂuorescent localization
studies revealed that the fs230 mutant primarily resides in the
endoplasmic reticulum. Although the fs260 mutant is also found
in the endoplasmic reticulum when it is expressed in REKs [4], a
signiﬁcant population escapes this compartment and reaches the
Golgi apparatus [4]. The importance of this ﬁnding is rooted in
the fact that Cx43 oligomerization does not occur in the
endoplasmic reticulum, possibly because of its interaction with
ERp19 [35], with ﬁnal oligomerization being delayed until the
Golgi apparatus [36]. Thus the bolus of the fs260 mutant in
the Golgi apparatus would have an increased opportunity to
oligomerize and inactivate co-expressed wild-type Cx43 by both
preventing further transport to the cell surface and inhibiting
channelfunction.OfalltheframeshiftandmissenseCx43mutants
examined to date, this characteristic of accumulating in the
Golgi apparatus is unique to fs260. Thus our results suggest that
the fs230 mutant is not as potent in causing skin disease and
this aetiology may not manifest in all patients harbouring this
mutation, as seems to be the case.
fs260-expressing REKs develop epidermal defects not observed by
other ODDD mutants
A major advantage in using the REK cell line is the ability
to model epidermal differentiation in culture. Surprisingly, all
cell lines examined retain the ability to differentiate and form
epidermal layers as found in thin skin. It was observed that
the full-length Cx43-expressing REKs did, however, form a
very compact stratum corneum. Since proper calcium signalling
in the upper stratum granulosum has been shown to facilitate
the release of keratohyalin granules, cleave stratum corneum
precursor proteins (proﬁllagrin) and activate transglutaminases
to cross-link proteins of the stratum corneum (loricrin) [37], over-
expression of functional Cx43 may enhance calcium signalling
and facilitate the formation of this phenotype. Morphological
evaluation of the organotypic epidermal cultures revealed that
the stratum corneum layer thickness was largest in the REK
cell lines which expressed Cx43 variants (Cx43 and  244*) that
both maintained their dye-transfer ability and the expression of
the most phosphorylated Cx43 species. Since cells expressing
both the Cx43 and  244* constructs developed a larger stratum
corneum, we suggest that functional Cx43 levels can enhance
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Figure 4 Cx43 mutant-expressing REKs differentiate into organotypic epidermis
REKs were plated on to collagen type I-coated well inserts and the medium from the upper chamber was removed to allow REKs to differentiate and stratify.( A) After two weeks of organotypic
differentiation, all mutant expressing Cx43 REK cell lines differentiated. To determine the extent of organotypic differentiation, histological sections of each organotypic culture were stained with
haematoxylin and eosin, imaged, and the upper stratum corneum and lower vital layer thicknesses were measured. (B) When comparing the stratum corneum height with total epidermal height,
there was a signiﬁcant decrease found in the G21R-, G60S-, G138R- and fs260-expressing cultures when compared with organotypic cultures derived from Cx43 expressing REKs. In addition,
parakeratosis was observed in the fs260-expressing cultures (arrows). *P <0.05.
the differentiation state of the epidermis. This is also supported
by evidence that Cx43 is enhanced during restratiﬁcation of the
epidermis during development and after wound healing [38–41].
Given that a feature of hyperkeratosis is an enlarged stratum
corneum, the observed decrease in the stratum corneum thickness
in the fs260-expressing organotypic cultures was not expected.
Since palmar plantar hyperkeratosis is only seen in a thick skin
environment, our organotypic epidermal cultures may model a
thin skin environment and not fully mimic the disease state
found in thick skin. In addition, the relatively short time period
used to establish organotypic epidermal cultures may only assess
how mutant Cx43 affects the development of the epidermis
and not represent the resulting steady state and maintenance
after differentiation. Over time, keratinocytes expressing ODDD-
associated mutants may undergo unnecessary proliferative and
regenerative events to result in an enlarged stratum corneum. The
fs260-expressing organoytpic epidermal cultures did, however,
revealnucleipresentinthestratumcorneum.However,thisfeature
is often observed in hyperkeratosis [42] and suggests that the
fs260-expressing keratinocytes may have a higher propensity to
develop hyperkeratosis in vivo.
Cx26 cross-talk with Cx43 mutants
To biochemically assess the differentiation state of these organo-
typic cultures, Cx26, loricrin and CK14 were evaluated using
Western blot analysis. Cx26 is normally expressed in the stratum
granulosum layer under terminal differentiation conditions and
this expression was found to be lower in the ODDD mutant
Cx43 expressing organotypic cultures as compared with REKs
over-expressing full-length Cx43. Mutant Cx26 has previously
been shown to be transdominant to Cx43 [23] and thus
mutant Cx43 may also be transdominant to Cx26. Since Cx26
mutants are strongly correlated with skin disease (hyperkeratosis)
[43–45], Cx43 mutants which reduce Cx26 levels may also
contributemechanisticallytoanyresultingskindiseasephenotype
and also wound repair [46].
Decreased levels of Cx43 may lead to epidermal barrier defects
Truncation of the C-terminal tail of Cx43 has previously
been shown to disrupt the epidermal barrier in mice [47].
To determine if the epidermal barrier function could also
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Figure 5 Assessment of endogenous and mutant Cx43, Cx26 and loricrin protein expression in organotypic epidermis
Western blots were performed on REK cells lines after 2 weeks of differentiation. (A) Anti-Cx43 N-terminal-speciﬁc antibody (Ab) was used to detect GFP-tagged mutant Cx43 variants, whereas an
anti-Cx43 C-terminal-speciﬁc antibody was used to detect endogenous Cx43 expression. (B) The G138R- and fs260-expressing REKs had signiﬁcantly lower total endogenous Cx43 levels when
compared with full-length Cx43 REKs. ODDD mutants also reduced the highly phosphorylated species of endogenous Cx43. Densitometry analysis of GFP-tagged Cx43 variants also revealed a
signiﬁcant decrease in the expression of the  244* mutant, whereas the expression of the fs230 mutant was signﬁcantly elevated. In addition, Western blot analysis of Cx26 (C) revealed that all
ODDD Cx43 mutants reduced the levels of Cx26 compared with cells expressing full-length Cx43, whereas loricrin (D) was only reduced in fs260-expressing REKs. *P <0.05 and #P <0.05.
be affected in REKs expressing mutant Cx43, transepithelial
resistancemeasurementsandanacetone-inducedinjuryassaywas
performed on organotypic cultures derived from each REK cell
line created. Although transepithelial resistance measurements
assess the paracellular barrier formed by tight junctions,
nevertheless, the introduction of Cx43 mutants lowered the
transepithelial resistance values but had no effect on the levels or
localizationofclaudin-1oroccludin,suggestingthatthecross-talk
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Figure 6 Cx43 mutant-expressing REKs exhibited reduced transepithelial resistance when compared with Cx43 overexpressing REKs in the absence of
changes in the expression or localization of junctional proteins
(A) Transepithelial resistance measurements of conﬂuent monolayer cultures were taken daily for 5days and the resistance from days 2–4 were averaged and plotted. (B) E-cadherin, claudin1 and
occludin were localized by immunoﬂuorescent labelling in REKs overexpressing GFP-tagged Cx43, G138R or fs260. Western blot analysis did not reveal any changes in the expression of occludin,
E-cadherin or claudin-1 (C and D). *P <0.05. Nuclei were labelled with DAPI (blue). GAPDH, glyceraldehyde-3-phosphate dehydrogenase
between the gap junction status and tight junctions may be at the
level of junction assembly and not at gene expression [48]. Given
that the G60S, G138R and fs260 mutants all moderately reduce
transepithelial resistance, palmar plantar hyperkeratosis cannot
be rooted solely to this ﬁnding. The fs260 mutant, however, did
cause the greatest decrease in transepithelial resistance, and since
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Figure 7 Acetone treatment increased the vital layer thickness in fs260-
expressing organotypic cultures
(A)OrganotypicculturesofREKsexpressingendogenousCx43oroverexpressingCx43orCx43
mutantswereleftuntreatedortreatedwithacetone.Notethatinfs260-expressingREKepidermis,
there were nuclei present in the stratum corneum (arrows). (B) Vital layer measurements of all
REK cell lines either untreated or treated with acetone revealed a signiﬁcant increase in the vital
layer thickness in both the vector and fs260-expressing REKs when compared with full-length
Cx43 expressing organotypic cultures. *P <0.05.
this mutant reduces the levels of phosphorylated Cx43, which is
typically reﬂective of assembled gap junctions, other junctional
complexes may be disrupted leaving the epidermis more prone
todysregulationwhenplacedunderstress.Thisinturnmayleadto
a proliferative response, an increase in epidermal thickness and
hyperkeratosis. Topical application of retinoic acid has been
used to treat hyperkeratosis [49] and retinoic acid treatment has
been shown to upregulate Cx43 expression [50,51]. Thus the
upregulation of Cx43 may promote and stabilize the formation
of junctional complexes and further maintain keratinocytes in a
non-proliferative state.
To further determine if keratinocytes expressing mutant Cx43
have a normal epidermal barrier, acetone was administered to
organotypic cultures and histological analysis was performed
after 1 week of injury. Acetone treatment has previously been
shown to induce a proliferative response in organotypic cultures
[28]. Organotypic cultures expressing full-length Cx43 formed
a compact epidermal barrier and no increase in the vital layer
was seen as found in cultures that lacked Cx43 overexpression.
However, a signiﬁcant increase in vital layer thickness was
observed in fs260-expressing organotypic cultures. Collectively,
these results suggest that Cx43, as well as most of the mutant
variants of Cx43, but not fs260, can protect against acetone-
induced injury.
Although all mutations in the gene encoding Cx43 lead to
ODDD, some mutations are clearly more potent, leading to skin
abnormalities. Typically, domain-speciﬁc Cx43 mutants all cause
oneormoremeasureabledefectsinprocessesrelatedtoepidermal
differentiation. However, the fs260 mutant consistently caused
quantiﬁable defects in REKs. In particular, organotypic cultures
grownfromcellsexpressingthefs260mutantdevelopedathinner
stratum corneum with nuclei often present and an enlarged
vital layer when exposed to acetone. We proposed that the
additive effects of these changes ultimately cause the skin disease
phenotype observed in ODDD patients that express this mutant.
Thus our ﬁndings demonstrate how one Cx43 mutant can cause
increased disease burden over and above that caused by other
Cx43 mutants.
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SUPPLEMENTARY ONLINE DATA
The potency of the fs260 connexin43 mutant to impair keratinocyte
differentiation is distinct from other disease-linked connexin43 mutants
Jared M. CHURKO, Stephanie LANGLOIS, Xinyue PAN, Qing SHAO and Dale W. LAIRD1
Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, Canada N6A 5C1
Figure S1 Microinjection of Lucifer Yellow into vector control and fs230-
expressing REKs
A single cell was microinjected with Lucifer Yellow (asterisks) in either vector or fs230-
mutant-expressing REKs. Lucifer Yellow was found to readily transfer to neighbouring cells in
only the vector control cells. Phase-contrast (left panels) and ﬂuorescent (right panels) images
wereacquiredtovisualizecellclustersandLuciferYellowdyetransfer.NotethattheGFP-tagged
fs230 mutant was also detected in the ﬂuorescent image.
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Figure S2 Western blot and quantiﬁcation of the endogenous p368
phosphorylated species of Cx43
Western blots revealed a signiﬁcant decrease in the p368 levels of Cx43 in both the fs260 and
 244* cells when compared with full-length Cx43-expressing REKs. *P<0.05.
1 To whom correspondence should be addressed (email dale.laird@schulich.uwo.ca).
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